Using the analysis of transcriptome data, Yue et al. [16] have demonstrated that in patients with BRCA1 deficient ovarian cancer the cAMP pathway is significantly activated, which is associated with increased expression of the ADRB1, β-adrenoreceptor genes. The gene discussed is BRCA1; the disease is ovarian cancer.